Catherine Y. Han

Materials ScienceMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial”.

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Clonal hematopoiesis and differential outcomes after immune checkpoint blockade

Cancer Cell(2022)10.1016/j.ccell.2022.08.024

N/A

0DataRank · unranked

30 citations

Hannah J. Sfreddo, Karena Zhao, Catherine Y. Han, Luc G.T. Morris, David Hsiehchen

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci169823

N/A

0DataRank · unranked

31 citations

Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall Fitzgerald, Mark Lee +17 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data

Nature Medicine(2025)10.1038/s41591-024-03398-5

N/A

0DataRank · unranked

111 citations

Conall Fitzgerald, Byuri Angela Cho, Bailey G. Fitzgerald, Catherine Y. Han, Elizabeth S. Koh +32 more